NANOSONICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.81 AUD | +3.31% |
|
-2.09% | -36.14% |
| 01/05 | Nanosonics Submits De Novo Application to US FDA for CORIS Cleaning Technology | MT |
| 15/03 | Nanosonics Chief Technology Officer to Retire | MT |
| Sales 2024 * | 167M 111M 9.26B | Sales 2025 * | 192M 127M 10.63B | Capitalization | 851M 565M 47.16B |
|---|---|---|---|---|---|
| Net income 2024 * | 8M 5.31M 443M | Net income 2025 * | 13M 8.63M 720M | EV / Sales 2024 * | 4.37 x |
| Net cash position 2024 * | 121M 80.31M 6.7B | Net cash position 2025 * | 131M 86.84M 7.24B | EV / Sales 2025 * | 3.76 x |
| P/E ratio 2024 * |
99.4
x | P/E ratio 2025 * |
65.1
x | Employees | 482 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Nanosonics Limited
More press releases
| 1 day | +3.31% | ||
| 1 week | -2.09% | ||
| 1 month | -0.71% | ||
| 3 months | +1.44% | ||
| 6 months | -31.63% | ||
| Current year | -36.14% |
1 week
2.70
2.93
1 month
2.703.05
Current year
2.594.45
1 year
2.595.26
3 years
2.597.52
5 years
2.598.25
10 years
0.748.25
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Kavanagh
CEO | Chief Executive Officer | - | 30/12/30 |
Jason Burriss
DFI | Director of Finance/CFO | - | 03/23/03 |
Sunny Pillai
CIO | Chief Investment Officer | - | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry Marshall
BRD | Director/Board Member | - | 03/23/03 |
David Fisher
BRD | Director/Board Member | - | 30/01/30 |
Steven Sargent
CHM | Chairman | 62 | 06/16/06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +3.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 2.81 | +3.31% | 1,321,967 |
| 30/24/30 | 2.72 | -4.56% | 1,109,938 |
| 29/24/29 | 2.85 | -1.38% | 933,183 |
| 28/24/28 | 2.89 | -1.03% | 985,171 |
| 27/24/27 | 2.92 | +1.74% | 401,366 |
Delayed Quote Australian S.E., May 31, 2024 at 11:40 am IST
More quotes
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. The Company's trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.
Calendar
19/08/2024
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2.81
AUD
Average target price
3.204
AUD
Spread / Average Target
+14.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.14% | 565M | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.6B |
- Stock Market
- Equities
- NAN Stock
